E-LIB Suche - Ergebnisse für: Pinto, Lana C

1

Dose-ranging effects of SGLT2 inhibitors in patients with t..:

Pinto, Lana C. ; Rados, Dimitris V. ; Remonti, Luciana R....
Archives of Endocrinology and Metabolism. 66 (2022) 1 - p. 68-76 , 2022

Link: https://doi.org/10.20945..

2

Type 2 diabetes as a major risk factor for COVID-19 severit..:

Pinto, Lana C. ; Bertoluci, Marcello C.
Archives of Endocrinology and Metabolism. 64 (2020) 3 - p. 199-200 , 2020

Link: https://doi.org/10.20945..

3

Patient-centered Management of Type 2 Diabetes Mellitus Bas..:

Pinto, Lana C ; Rados, Dimitris V ; Remonti, Luciana R...
The Journal of Clinical Endocrinology & Metabolism. 105 (2020) 11 - p. 3588-3599 , 2020

Link: https://doi.org/10.1210/..

4

Glucagon-like peptide-1 receptor agonists and pancreatic ca..:

Pinto, Lana C. ; Falcetta, Mariana R. ; Rados, Dimitris V...
Scientific Reports. 9 (2019) 1 - p. , 2019

Link: https://doi.org/10.1038/..

5

Dipeptidyl peptidase-4 inhibitors, pancreatic cancer and ac..:

Pinto, Lana C. ; Rados, Dimitris V. ; Barkan, Sabrina S...
Scientific Reports. 8 (2018) 1 - p. , 2018

Link: https://doi.org/10.1038/..

6

Screening for coronary artery disease in patients with type..:

Rados, Dimitris V ; Pinto, Lana C ; Leitão, Cristiane B.
BMJ Open. 7 (2017) 5 - p. e015089 , 2017

Link: https://doi.org/10.1136/..

7

Type 2 diabetes as a major risk factor for COVID-19 severit..:

Pinto, Lana C ; Bertoluci, Marcello C
10.20945/2359-3997000000256. , 2020

Link: http://www.scielo.br/sci..

8

Dipeptidyl peptidase-4 inhibitors, pancreatic cancer and ac..:

Pinto, Lana C ; Rados, Dimitris V ; Barkan, Sabrina S..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768864/. , 2018

Link: http://www.ncbi.nlm.nih...

9

Dose-ranging effects of SGLT2 inhibitors in patients with t..:

Lana C. Pinto ; Dimitris V. Rados ; Luciana R. Remonti...
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972022000100068&tlng=en. , 2022

Link: https://doi.org/10.20945..

10

Type 2 diabetes as a major risk factor for COVID-19 severit..:

Lana C. Pinto ; Marcello C. Bertoluci
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972020000300199&tlng=en. , 2020

Link: https://doi.org/10.20945..

11

Dipeptidyl peptidase-4 inhibitors, pancreatic cancer and ac..:

Lana C. Pinto ; Dimitris V. Rados ; Sabrina S. Barkan..
https://doi.org/10.1038/s41598-017-19055-6. , 2018

Link: https://doi.org/10.1038/..

12

Controle inadequado da pressão arterial em pacientes com di..:

Lana C. Pinto ; Eliza D. Ricardo ; Cristiane B. Leitão...
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2010000500013. , 2010

Link: https://doaj.org/article..

13

Accretionary and collisional processes of the Brasiliano Or..:

Pinto, V.M. ; Debruyne, D. ; Leitzke, F....
Precambrian Research. 399 (2023) - p. 107226 , 2023

Link: https://doi.org/10.1016/..

14

Metamorphic evolution of a Tonian eclogite associated with ..:

Pinto, V.M. ; Debruyne, D. ; Hartmann, L.A....
Precambrian Research. 366 (2021) - p. 106414 , 2021

Link: https://doi.org/10.1016/..

15

CCL2 and IFN-γ serum levels as biomarkers for subclinical i..:

Queiroz, Edson A. ; Medeiros, Nayara I. ; Mattos, Rafael T....
Microbial Pathogenesis. 150 (2021) - p. 104725 , 2021

Link: https://doi.org/10.1016/..